Why the study?
Does the ACE I allele prevent coronary artery disease in patients undergoing cardiac catheterization?
Does the ACE I allele prevent coronary artery disease in patients undergoing cardiac catheterization?
The ACE I allele is associated with a lower risk of significant coronary artery disease in patients undergoing cardiac catheterization.
Answers are grounded in this paper and cite their sources.
Does not support ACE genotyping for CAD risk stratification; leaves open causal protection versus confounding in catheterization cohorts.
BACKGROUND: Mutations in genes regulating lipid metabolism, vasoactivity, and coagulation are important modulators of coronary artery disease (CAD). OBJECTIVE: This study investigated the association between allelic variants of the angiotensin converting enzyme (ACE), methytetrahydrofolate reductase, plasminogen activator inhibitor-1 and factor V genes and CAD. METHODS: Clinical, biochemical, and angiographic information were collected from 300 patients who underwent cardiac catheterization and their DNA was genotyped by restriction fragment length polymorphism. RESULTS: The frequency of the D allele of the ACE gene was significantly higher than the I allele in patients with more than 70% stenosis in any vessel. Among patients with more than 70% stenosis, carriers of the D allele were 2.8 times more likely to be males. The presence of the ACE I allele was negatively associated with CAD with (P=0.02 ,OR=0.38.) CONCLUSION: This study describes a protective role of the ACE I allele in individuals who may be at risk of developing CAD.
No takes yet. Share an insight, caveat, or question.
Abchee et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: